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1. Introduction 
Moulds constitute the largest group of bacteria, prevailing both in the indoor and outdoor 
air. Approximately 200 000 species of moulds have been identified so far, where only a small 
group of around 200 may present a threat to human health.  Fungi from Aspergillus species 
are among the moulds considered to be most pathogenic. They also constitute the group of 
most pathogenic moulds most frequently isolated from the environment. Over 250 types of 
this species are known; about 50 of them were precisely described before the year 2000 
(Klich, 2009). Pathogenicity, due to their toxicity, was also documented in other species: 
Aspergillus fumigatus, Aspergillus flavus, Aspergillus ochraceus, Aspergillus niger, Aspergillus 
versicolor, Aspergillus parasiticus. Aspergillus nidulans, Aspergillus ustus, Aspergillus glaucus, 
Aspergillus clavatus, Aspergillus sydowii and Aspergillus terreus. Their taxonomic identification 
is still an open topic because of their morphological variability and ability to produce 
metabolites; new species which exhibit adverse health effects to humans are constantly 
being detected. Aspergillus lentulus is one of the recently detected species of considerable 
clinical importance; it reveals similarity to Aspergillus fumigatus, one of the most pathogenic 
fungus for humans (Balajee et al., 2005).Table 1 presents the classification of species of fungi 
pathogenic to humans from the Aspergillus species. The list has been created by the authors 
of “Atlas Grzybów Chorobotwórczych Człowieka" ("Atlas of Fungi Pathogenic to Humans") 
(Krzyściak et al., 2011). 
2. Fungal metabolites of Aspergillus species present a threat for human 
health 
In their metabolic process, moulds produce mycotoxins. Those natural products, poisonous 
to humans and animals, are created as the result of a secondary metabolic process of fungi, 
when grown on organic substrates. Chemical structure of these metabolites varies, however, 
they are largely of small molecular mass, which  conditions their varied toxic characteristics. 
So far over 400 metabolites produced by moulds have been identified from different genus 
of fungi: Aspergillus sp., Penicillium sp., Fusarium sp., Alternaria sp. Trichothecium sp. or 
Stachybotrys sp. Secondary metabolites of fungi from Aspergillus species are: ochratoxin A, 
aflatoxin B1, aflatoxins G1 and M1, trichothecenes, sterigmatosystin, patulins, gliotoxins or 
cyclopiazonic acid. Table 2 presents metabolites produced by the selected, most pathogenic 
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Subtype  Section Teleomorph Species linked to infections in humans  
Aspergillus Aspergillus Eurotium  A. chevalieri (Eurotium chavalieri) 
A. glaucus (Eurotium herbariorum) 
A. hollandicus (Eurotium amstelodami) 
A. reptans (Eurotium repens) 
A. rubrobrunneus (Erotium rubrum) 
A. sejunctus 
Restricti  A. caesiellus 
A. conicus 
A. pencilliodes 
A. restrictus 
Fumigati Fumigati Neosartorya A. fischerianus (Neosartorya fischeri) 
A. fumigatus 
A. fumisynnematus 
A. lentulus 
A. spinosus (Neosartorya spinosa) 
A. thermomutans (Neosartorya 
pseudofischeri) 
A. viridinutans 
Neosartorya coreana – no confirmation of 
pathogenicity in humans 
Neosartorya fennelliae - no confirmation 
of pathogenicity in humans 
Neosartorya hiratsukae 
Neosartorya udagawae 
Cervini   
Ornati Ornati Neocarpentels  
Clavati Clavati n.n. A. clavatoanicus 
A. clavtus 
Nidulantes Usti  A. calidoustus 
A. deflectus 
A. ustus 
Versicolores  A. granulosus 
A. janus 
A. sydowii 
A. versicolor 
Terrei Fennellia A. alabamensis 
A. terreus 
Flavipedes Fennellia A. carneus 
A. flavipes 
A. niveus (Fennellia nivea) 
Nidulantes Emericella A. nidulans (Emericella nidulans) 
A. quadrilineata A. tetrazonus 
(Emericella quadrilineata) 
A. unguius (Emericella unguis) 
Circumdati Circumdati Neopetrmyces A. alutaceus (isolated from sputum, 
pathogenicity not confirmed in 
humans) 
A. ochraceus 
A. sclerotiorum 
Flavi Petromyces A. alliaceus 
A. avenaceus 
A. beijingensis 
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A. flavus var. oryzae (A. oryzae 
teleomorph: Eurotium oryzae) 
A.  flavus 
A. tamarii 
Nigri Petromyces, Saitoa A. (niger var.) awamori 
A. aculeatus 
A. atroviolaceus 
A. japonicus 
A. niger 
Candidi  A. candidus 
Wentii Chaetosartorya  
Cremei   
Sparsi  A. wangduanlii 
Stilbothamnium    
Ochraceoroseus    
n.n. n. n.  A. qizutongii 
A. ochraceopetaliformis 
Table 1. Classification of pathogenic to humans Aspergillus species.  
to humans Aspergillus species . (Krzyściak et al., 2011; Bräse et al., 2009;  Skaug et al., 2001; 
Pitt et al., 2000; Smith et al., 1995) 
 
No Species  Metabolites 
1 Aspergillus fumigatus gliotoxin, verruculogen, fumitremorgin A and B, 
fumitoxin, tryptoguivaline, fumigallin, helvolic acid 
, sphingofungins, brevianamide A, coumarin 
2 Aspergillus flavus kojic acid, 3-nitropropionic acid, cyclopiazonic acid, 
aflatoxin B1, B2, G1, G2, aspergillic acid, 
violaxanthin,  aspertoxin 
3 Aspergillus niger naphto-g-pyrones, malformin, ochratoxin A, toxic 
oxalates, violaxanthin 
4 Aspergillus ochraceus penicillic acid, ochratoxin A and B, xanthomeganin, 
viomellein, violaxanthin, circumdatin A, B, C 
5 Aspergillus versicolor sterigmatocystin, nidulotoxin,  antrachinons, 
anthraquinoid 
6 Aspergillus candidus kojic acid, terphenyllin, candidulin, xanthoascin, 
beta nitropropionic acid 
7 Aspergillus terreus terreic acid, patulin, citrinin, citreoviridin, 
lovastatin, gliotoxin, terrain, patulin 
8 Aspergillus nidulans sterigmatocystin, penicillin, cotanin, nidulotoxin 
9 Aspergillus clavatus patulin, cytochalasin E, tryptoguivaline, kojic acid, 
clavatol, kotanin 
10 Aspergillus lentulus gliotoxin, cyclopiazonic terreic acid, neosartorin, 
auranthine and pyripyropenes A, E  
11 Aspergillus parasiticus Aflatoxins A1, B1, G1, G2 
 
Table 2. Metabolites of selected species of Aspergillus fungi. 
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Natural metabolites produced by fungi are for the most part cytotoxic to different cellular 
structures and depress their key processes such as RNA and DNA synthesis (Burr, 2001). 
Mycotoxins differ with respect to their nature, action towards target cells, cellular structures 
and their internal processes. Best described mycotoxins produced by fungi of the Aspergillus 
species are aflatoxins and ochratoxins. Aflatoxins are highly saturated heterocyclic 
compounds which contain elements of furan. Ochratoxins constitute a group of poliketides 
derived from isocoumarin, related to L-phenylalanine. Degradation of ochratoxin A within 
the human body produces (4-R)-4 hydroxyochratoxin A and ochratoxin α, which create an 
albumin bond in the plasma. Creation of such bond facilitates the substances` persistence in 
the human body for an extended period of time (Budak, 1998). 
Influence on the health in exposed individuals exerted by secondary metabolites includes 
carcinogenic, teratogenic, mutagenic, hepatotoxic and nephrotoxic action (it particularly 
concerns aflatoxin A1 and ochratoxin A) (Fischer & Dott 2003;Burr, 2001). Sterigmatocystin is 
one of the aflatoxin precursors on its biosynthesis pathway and its carcinogenic action is 
only slighly lower than that of aflatoxin itself. Gliotoxin is considered to be responsive to 
immunosuppression and cellular apoptosis; it is also a likely virulence factor in mycoses 
caused by A. fumigatus. Gliotoxin is a very frequently detected toxin in the serum of patients 
suffering from aspergillosis. (Bok et al., 2005). This toxin is present in the serum of animals 
with a natural A. fumigatus infection and in cancer patients with invasive aspergillosis 
(Lewis et al., 2005).  
This was confirmed in the findings obtained by Kupfahl, in which analysis of gliotoxin was 
performed in 158 Aspergillus strains (100 A. fumigatus) originating from patients with 
invasive aspergillosis and from the environment. During analysis of the strains and their 
ability to produce gliotoxin he discovered that gliotoxin was detected in the majority of A. 
fumigatus strains isolated both from clinical materials and from the environment (98% and 
96% respectively) (Kupfahl et al., 2008). 
The variety of metabolites produced by fungi of the Aspergillus species ( A. fumigatus 
produces as well  fumigallin, helvolic acid, tryptoguivaline, A. candidus kojic acid, 
terphenyllin, A. ochraceus penicillic acid or viomellein, while A. niger produces malformin) 
equips the fungi with multiple options of invading the host`s body, at the same time 
limiting the therapeutic options resulting from targeted prophylaxis. As it turns out, 
applying targeted chemoprophylaxis does not always prove to be effective, as the medicine 
does not affect all of the metabolites produced just by one strain of fungi (Bräse et al., 2009; 
Domsch et al, 2007; Ribeiro et al., 2005; Raper & Fennell, 1965). 
3. Epidemiology of infection and clinical health outcome, as caused by fungi 
of the Aspergillus species 
Fungi of the Aspergillus species are typical isogenic opportunistic bacteria, which for the 
most part fail to trigger an infection with a healthy person; however, they constitute a threat 
predominantly to persons with immunity disorders. Factors which facilitate the conditions 
necessary for a fungal invasion are: disturbances in the functions of T lymphocytes, 
phagocytes as well as the reticuloendothelial system, chemo- and radiotherapy, skin 
incisions related surgery, therapy or care. Risk factors for developing an invasive 
aspergillosis are chronic neutropenia (exceeding 3 weeks), corticosteroid treatment, 
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hematological neoplasms, cytotoxic treatment, AIDS- Acquired Immune Deficiency 
Syndrome and bone marrow transplant. Certain influence has also been attributed to 
cytomegalovirus (CMV) contraction. Treatment with infliximab, a monoclonal antibody 
against tumour necrosis (TNFα), has been described in literature as being a determining 
factor for aspergillosis. Mechanisms, through which the predisposition factors intensify 
invasiveness of fungi of the Aspergillus species, act through or directly at the host, or the 
fungus, or both. Factors which determine pathogenicity of the Aspergillus fungi are multiple 
polar or neutral lipids, phenolic compounds and heterocyclic toxins (mycotoxins). An 
additional factor intensifying the pathogenicity of the Aspergillus fungi is their capacity to 
produce various proteolytic enzymes e.g. protease, which assist fungal colonisation in the 
infected host tissues (Türel, 2011; Kurnatowski &Miśkiewicz, 2009; Macura, 1998).   
A source of infection with Aspergillus fungi may be another infected person, in whose body 
the fungal process develops, but primarily it is the hospital environment: air, water pipe 
system, ventilation system, hospital food as well as the medical equipment. For isogenic 
fungi of the Aspergillus type the obvious portal of entry is the respiratory system of a sick 
person, as well as skin with lesions, e.g. a burn or damaged cornea. Infection within the 
respiratory system develops as a result of inhalation of the fungal spores present in the air. 
Very often, prior to development of aspergillosis, a patient`s oronasal cavity is subject to 
fungal spore colonization. A developing fungus located in the lungs (incubation period 
spans between 2 days to 3 months) results in haemorrhagic infarctions, which cause a 
further transmission of the infection through the bloodstream to the brain, liver, spleen, 
kidneys, pericardium or skin (Mortensen, 2011; Garczewska, 2008)  
 For patients with lymphopenia - where the number of CD4 cells is lower than 0.2 x 10e9/l - 
most of the cases where the respiratory tract is colonized with Aspergillus, aspergillosis may 
develop as a result. With immunosuppressed patients, e.g. those suffering from 
hematological neoplasms, the most predominant form of fungal infection is invasive 
aspergillosis in 70% of cases caused by A. fumigatus. A variant of aspergillosis a little less 
common is general aspergillosis which affects central nervous system, sinuses, kidneys, skin 
or bones. Observational studies (a five year period of observation carried out on 3228 
patients who underwent HSCT (haematopoietic stem cell transplant) at 11 transplant wards 
in Italy, where fungal infection prophylaxis was implemented by means of use of 
fluconazole, fungal infections were  observed in 121 patients (3.7%), where 75% of cases 
were invasive aspergillosis, mostly of Aspergillus aetiology (Asano-Mori, 2010; Pagano, 
2007). Unfortunately, Aspergillus fungal infections display a high mortality rate. In untreated 
aspergillosis, mortality rate can soar as high as 100%, and in the cases where treatment is 
introduced it drops only slightly down to 60%.  One of the patient groups highly susceptible 
to invasive fungal infections caused by Aspergillus is the hematooncologic patients, where 
mortality rate with chemotherapy patients is as high as 49.3%, and with patients who 
underwent a haematopoietic stem cell transplant it reaches 86.7%. It was also shown that 
invasive aspergillosis is prevalent more often with the allogeneic bone marrow transplant 
patients (2.9-16.0%), rather than with those who underwent the autologous bone marrow 
transplant (0.3-1.1%) (Butrym et al., 2011; Fraquet et al., 2004). Uncharacteristic symptoms 
and diagnostic difficulties represent a key reason for delayed diagnosis of the infections 
caused by the fungi of Aspergillus species and deferred commencement of adequate 
treatment. Chamilos et al. in their research showed that as many as 75% of fungal infection 
cases confirmed in post mortem analysis were not diagnosed when the patients were still 
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alive (Chamilos  et al., 2008). Very often symptoms of fungal infections caused by moulds, 
are misdiagnosed as bacterial infections. A success case of a 47-year old woman suffering 
from sarcoidosis, who had been treated with steroids, and for two years had a confirmed 
lung cavity, indicates that a successful treatment of aspergillosis is possible. In that case, 
major symptoms of the disease were high fever, chronic cough with sputum, weight loss 
and hemoptysis. After an ineffective course of antibiotic therapy, the patient was diagnosed 
with candidiasis and semi-invasive aspergillosis. A computer tomography (CT) scan 
revealed a mycetoma in the lung cavity, culture of the sputum revealed an Aspergillus 
infection, and a significant improvement after antifungal treatment confirmed the diagnosis 
of aspergillosis caused by fungi from A. niger (Kosacka et al., 2010).  
At present, the most sensitive test able to confirm aspergillosis is a high resolution CT scan 
in conjunction with the galactomannan test, which detects the antigen peculiar to 
Aspergillus. Other molecular recognition techniques based on PCR reaction are also used in 
detecting nosocomial aspergillosis. Genetic material of a fungus in clinical materials can be 
isolated by certain starters, e.g. from the sequence of alkaline proteinase or on the basis of 
26SrRNA (Kriengkauykiat et al., 2011; Garczewska, 2008, Kędzierska et al., 2007) 
Most common forms of nosocomial infections with moulds from the Aspergillus species are 
as follows: 
 aspergilloma located in the lungs, usually after tuberculosis 
 invasive aspergilloma (usually the pulmonary variation - in immunocompromised 
patients, leukaemia and post-transplant patients, in children suffering from chronic 
granulomatous disease) 
 paranasal sinus aspergillosis (in immunocompromised patients) 
 central nervous system aspergillosis (accompanies its disseminated version or as a 
result of sinusitis) 
 Aspergillus endocarditis and cardiac aspergillosis - (follow an open-heart surgery) 
 eye aspergillosis, endophtalmitis (in patients with endocarditis and following an organ 
transplant, often as the result of eye injury or transmission via bloodstream) 
 aspergillosis of the bone marrow (bone marrow aspergillosis) - in children with 
granulomatous disease  
 disseminated aspergillosis - as oesophageal infection, infection of the intestines, or 
organ infection: liver, spleen or kidneys.  
 chronic necrotising pulmonary aspergillosis - in patients with pulmonary diseases 
 skin aspergillosis - in patients with catheters or as the result of transmission via 
bloodstream. 
  allergic bronchopulmonary aspergillosis (asthma) - inhaling spores of fungus by 
persons allergic to its antigens (Garczewska, 2008). 
As previously mentioned, fungi from Aspergillus fumigatus species bear most significant 
clinical relevance for humans. This fungal species may cause acute and chronic inhalatory 
respiratory tract infections (aspergillosis, aspergilloma) as well as infections of the 
hematopoietic system, digestive system, genitourinary tract, skeletal muscles, and 
nervous system. The primary focus of infection in such cases is usually located in the 
lungs. Another pathogenic species which causes infections of the respiratory system and 
which also may cause allergic aspergillosis is Aspergillus flavus. This fungus is also 
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responsible for cases of chronic invasive sinusitis as well as deep fungal infections (of the 
kidneys, endocardium, and central nervous system). Aspergillus ochraceus may be the 
cause behind antromycosis, pulmonary invasion and onychomycosis. Fungi of the 
Aspergillus niger species may also cause infections of the inner and outer ear (otomycosis) 
as well as pulmonary aspergillosis. Similarly to other species of the Aspergillus species, it 
rarely is responsible for surface aspergillosis. Aspergillus versicolor may constitute an 
etiological factor for otomycosis, osteomylitis, skin lesions or pulmonary diseases. 
Recently, clinical significance has been attributed to infections caused by Aspergillus 
terreus. Its spores may cause an allergic reaction or invasive aspergillosis of the 
respiratory system, as well as infections of the skin, eye or liver. Aspergillosis in patients 
with compromised immunity has been attributed more frequently to this species. In 
retrospective research spanning over 10 years, carried out in Austria (Medical University 
Hospital of Innsbruck), for 67 cases of invasive aspergillosis, nearly half (32) were 
infections caused by A. terreus, while the remaining cases were attributed to other species 
of Aspergillus (Lass-Flörl  et al., 2005). 
4. Environmental factors facilitating development of fungi of the Aspergillus 
species 
Environmental parameters adding up to microclimate of rooms which affect  people`s 
physical state comprise: air temperature, relative humidity, airflow in the people zone, 
purity of the air - both with respect to chemical and microbiological cleanliness, intensity of 
smells, light and noise levels. Indoors, microclimate is made up of the following factors: 
outdoor climate, heating and ventilation, people in the room, technological processes which 
take place inside, thermal characteristics of the room (Kaiser, 2011).  
Indoor environment is an active ecosystem which evolves as the time progresses, with 
changes in humidity, temperature, presence of other microorganisms. Humidity in  the 
rooms designated for people should be between 30-70%. Excessively humid air encourages 
multiplication of microorganisms (bacteria, mould), decomposition and water condensation, 
which increases microbiological contamination of the air. Depending on their designation, 
temperature in hospital rooms is maintained at different levels, usually falling into the 22-
25°C temperature brackets.  
Moulds grow mainly in the environment where air humidity exceeds 45%, temperature is 
within the range of 5°C-35°C (optimum 18°-27°C), and water activity aw exceeds 0.8. Such 
environment is conducive to production of secondary metabolites – mycotoxins. 
Penicillium and Aspergillus are dominating mould species in the rooms where water 
activity is around 0.85 (Jarviss, 2003). Coefficient of hygroscopic expansion aw for fungi is 
lower than for bacteria, for the latter the prerequisite for development is the 0.99 to 0.995 
range. Fungi of the A.flavus type belong to the group of fungi which require higher air and 
soil humidity. It requires a 0.902 aw level, which constitutes an extremely humid 
environment (Zyska, 1999). 
Development of fungi may be affected by light in many different ways. Depending on the 
species, light may inhibit spore development or cause its abundant growth. It has been 
found that with one of the Alternaria species light of wavelength of 0.415xm-0.49xm 
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completely blocks spore development, while wavelength below 0.39xm and exceeding 
0.5xm stimulates spore growth (Zyska, 2001). 
Influence of hydrostatic pressure on fungi growth has not been adequately researched. 
Fungi show no sensitivity to hyperbaria. Fungal endospores display a unique resilience to 
high pressure. Osmotic pressure inside hyphae of some species may be as high as 4255 hPa 
(Kurnatowska, 1998). Mould conidia of A.niger do not show sensitivity to pressure of 
1000MPa. Growth of most yeast is halted, however, at pressure levels of as little as 0.8 MPa. 
A considerable drop in the hydrostatic pressure - hypobaria, or even deep vacuum, do not 
pose a threat to cells of many types of fungi. Deep vacuum had little or no impact on fungal 
vegetative forms and endospores, e.g. those from the Cheatomium globosum, Aspergillus 
oryzae, and Aspergillus terreus species (Piotrowska, 2000). 
From among external environmental chemical factors, the most important is acidity or 
alkalinity, which is measured in pH parameters. Lowest and highest values on the pH scale, 
within the boundaries of growth of a fungus, represent the scope characteristic for a given 
species. This factor ranging between 5 to 6 is appropriate for most fungi. As in the majority 
of cases fungi favour pH below 7, most may be labelled acidophilic. Many species of 
Aspergillus, Penicillium, and Fusarium may grow at pH close to 2. At the same time, species 
like Penicillium variabilis i Fusarium oxysporum thrive in the environment where pH reaches 
11. It should also be added that fungi trigger a shift in pH levels in the soil they grow in 
(Haasum & Nielsen, 1998). 
Fungi belong to aerobes or facultative anaerobes. An oxygen increase in the environment 
lowers the mycelium mass and starts a degenerative process, however, it does not destroy 
the fungus. An increase in carbon dioxide content also halts the growth of a fungus 
(Kurnatowska, 1998). 
From among moulds, fungi of the Aspergillus species demonstrate highest pathogenicity; 
however, despite their prevalence in the environment, they produce fewer mycotoxins than 
the less prevalent mould of Stachybotrys. It is not a rule of the thumb for all fungi of the 
Aspergillus species, as sterigmatocystin produced by Aspergillus versicolor may produce 
approximately 1% of the total biomass of fungi from this species, with water activity at level 
1. This fungus is rarely obtained from indoor environment, as the species occurs in colder 
regions, in mountain and polar climatic zones. Fungi most often isolated from the indoor air 
belong to A. fumigatus and A. niger species (Fog Nielsen, 2003). 
Among all the microorganisms present in the indoor air, moulds are most prevalent, 
however, it is crucial to remember, that live microorganisms (bacteria and fungi) make up 
only 10% of the total microorganism mass. Survivability of bacteria and moulds in the air is 
contingent upon peculiar to species susceptibility to desiccation and to the impact of 
ultraviolet rays. Most susceptible to desiccation are the vegetative forms of bacteria, while 
the most resilient are fungal spores. Fungal spores measure between 1.5 to 20 μm. One of the 
largest spores are: Rhizopus 4- 6 μm,  Mucor 4-8 μm, Fusarium 2.4-3.5 μm, A. niger 2.5-3.5 μm, 
A. flavus 3.5-4.5 μm, while the smallest spores belong to the most pathogenic species of the 
Aspergillus species: (A. terreus 1.5 – 2.5 µm, A. fumigatus 2.5 - 3 µm, or A. versicolor 2 -3.5 µm) 
(Krzyściak at al., 2011). Figures 1-3 present a scanning microscope image, showing 
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conidiophores of fungi of the following species: A. candidus, A. niger and A. flavus. Images 
from author`s own collection. 
 
Fig. 1. Aspergillus candidus as seen under the scanning microscope; magnified by 1500x. 
 
Fig. 2. Aspergillus niger as seen under the scanning microscope; magnified by 1000x. 
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Fig. 3. Aspergillus flavus as seen under the scanning microscope; magnified by 1000x. 
In contained rooms, not equipped with specialist ventilation systems and adequate air 
filtration, fungi and certain bacteria colonize places favourable to their development. Such 
areas are usually polluted places with increased humidity levels: ventilation shafts, air 
filters, noise reducing filters, insulation layers, air coolers, humidifier systems. Infected areas 
of such systems present a secondary source of microbiological contamination of the air. 
Ventilation and air-conditioning systems are more responsible for polluting the air with 
fungi than with bacteria. Most serious air infections happen in places where condensation is 
present. The risk increases if the systems are not properly utilised and if the air contains 
significant amounts of pollutants (Kaiser, 2011).  
Required cleanliness level of air provided for indoors is achieved by filtration by means of 
air conditioning systems and ventilation equipped with proper filters. For indoor spaces 
with high hygienic standards it is crucial to implement the use of multi-tier filtration 
systems. A modern air-conditioning system contains a laminar flow ceiling cabinet. Such 
system for operating rooms (hospital rooms with high standards of microbiological 
cleanliness) should provide the necessary amount of fresh air and an adequate frequency of 
airflow changes per hour. A factor that may limit the occurrence of infections with patients 
who undergo surgery is creating an environment free from bacteria as well as keeping the 
surgery time as short as possible (Kremer et al., 2010). Knochen et al. in a study that 
compared environments of operating theatres, where floors were routinely disinfected after 
each surgery, with those where theatres were cleaned only when visible dirt appeared, and 
concluded that none of the procedures influences the number of infections occurring in 
patients undergoing surgery. Utilizing a laminar flow ceiling cabinet proves to be a 
sufficient bacteria limiting method (Knochen et al., 2010). 
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The problem of providing microbiological cleanliness inside hospital rooms is not 
exclusively related to observing the principles of air filter exchange in air conditioning 
systems according to manufacturer`s instructions. According to Kaiser (Kaiser, 2004),  
periodical ventilation of the air-conditioning system is necessary as well as drying the 
ventilation pipes and elements of the equipment. He also states that air-conditioning system 
should not be completely shut off . On the contrary, Dettenkofer et al. suggest that shutting 
off the ventilation systems in the operating rooms when they are not in use probably does 
not increase microbiological contamination of the indoor air shortly after the system is 
switched back on (Dettenkofer et al., 2003). 
Proper utilisation of operating rooms also entails isolation of the inner environment from 
any possibility of contamination access from outside, by maintaining a pressure difference 
between the inner and outer rooms. Where proper ventilation systems are unavailable, 
limiting microbiological contamination from staff may result in an approximate twofold 
reduction in infections. Conclusions of research carried out by Lidwell suggest that with a 
drop in microbiological contamination concentration of the air below 10 c.f.u/m3, the drop 
in risk of infection is minor (Lidwell, 1982). With such low levels of concentration of bacteria 
in the air, transmission of infectious pathogenic microorganisms this way becomes a less 
serious cause of infection.  
4.1 Influence of physical and chemical factors on cytotoxicity of fungi 
Fungi are not cytotoxic unless there are circumstances enabling them to produce 
metabolites. The factors conducive to toxin production include: culture medium, life cycle of 
the fungi, availability of nutrients, environmental conditions and/or the simultaneous 
presence of other moulds [Kelman et al., 2004; Pitt et al.,2000). It has been established that in 
laboratory settings fungal monocultures lose their toxin production potential (Jarvis & 
Miller, 2005). Environmental conditions considerably influence the synthesis of fungal 
virulence factors. When fungal receptors receive variations in such factors as moisture, 
temperature, water activity and the presence of nitrogen, a signal transduction cascade that 
controls effector genes expression may be activated, which results in toxin production. The 
processes of sporulation and mycotoxin production in the Aspergillus  fungi are regulated by 
the protein G transduction signals pathway (Singh & Del Poeta, 2011). The investigations 
carried out by Watanabe et al. gave evidence that good environmental conditions, in this 
case oxygenation, stimulated the A. fumigatus fungi to gliotoxin production and were 
conducive to the increase of their general cytotoxicity (Watanabe et al., 2004). 
The presence of the Aspergillus fungi in the human environment does not necessarily cause 
infection in risk group patients. Those fungi are opportunistic bacteria and are cleared away 
by means of natural defence mechanisms in healthy individuals, however, they produce 
severe invasive infections in immunosuppressed patients. So far, the threshold value 
establishing a requisite for opportunistic infection has not been determined. Therefore, the 
goal of preventive action should be to eliminate Aspergillus fungi from human environment.  
Such aim, however, is hard to attain as, obviously, among all bacteria in the air, moulds are 
most numerous. Methods of absolute elimination of mould spores from the environment 
have been known, though. Nevertheless, from a practical point of view it is not feasible. 
Bearing in mind immunosuppressed patients, the Airinspace Technologies system was 
created. It is based on creating a protective chamber around a patient, where air exchange 
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takes place 60 times per hour, with the use of plasma as a bacteria killing agent, it is still 
very difficult to provide a patient with ultra-sterile air  (Poirot et al., 2007).  
Our own study on mycological cleanness of hospital rooms indoor air revealed that the 
Aspergillus species amounted to 20-38% of all of the moulds isolated, and the most 
frequently identified species was A. fumigatus [Gniadek et al., 2010; Gniadek et al., 2009). 
Domination of this species in the indoor air may be tantamount to a high risk of infection. 
The risk may be confirmed by the findings of Aspergillus cytotoxicity evaluation in such sites 
as adult intensive therapy ward, intensive neonatal care unit and chemotherapy and 
radiotherapy wards. The analysis was performed using an MTT test (3-(4.5-dimethylthiazol-
2-yl) 2.5 diphenyltetrazolium bromide) in which general cytotoxicity was tested on swine 
kidney cells (SK), sensitive to most mycotoxins. The test is based on the reduction of yellow 
MTT tetrazolium salt to violet formazan, insoluble in water. The reduction occurs in the 
presence of intact SK, not damaged by mycotoxins. The intensity of reaction is proportional 
to the amount of metabolically active SK. When the SK are infected with moulds producing 
mycotoxins, their mitochondria fail to reduce tetrazolium salt into formazan. Therefore, 
when the SK are damaged by mycotoxins, the reaction is less intensive or does not occur, 
which can be measured photometrically as more or less intensive change of colour. Thus, 
the reduction or the absence of the reaction gives evidence of cytotoxicity of the fungal 
strain tested (Hanelt et al., 1994). 
The analysis comprised the evaluation of a test sample (Petri dish with the moulds on 
Czapek medium) and a control sample (Petri dish with Czapek medium). The SK were 
grown in medium containing antibiotics (penicillin and streptomycin, Sigma Aldrich) and 
calf fetal serum (Sigma Aldrich) in the Hera Cell incubator with carbon dioxide, 
manufactured by Heraeus (5% CO2, 37°C, 98% humidity). The number of SK was 2.2×105. 
The ranges of testing concentrations were prepared in the ratio 1:2 and amounted from 
31.251 to 0.061 cm2/l. The value was expressed in terms of cm2/ml, where the area of the 
Petri dish from which the moulds were extracted together with the medium, was measured 
in square centimetres.  
The quantitative evaluation of cytotoxicity was performed using a microslide 
spectrophotometer (Elisa Digiscan reader, Asys Hitech GmbH, Austria) and the programme 
MikroWin 2000 (Mikrotek Laborsysteme GmbH, Germany). The readings were made at the 
wave-length of 510 nm. All of the absorption values below 50% of the threshold activity 
were considered as toxic. So, the borderline toxic concentration was evaluated on the basis 
of the dilution i.e. the mean inhibitory concentration IC50 was equal to the smallest sample 
(in cm2/ml) which was toxic to the SK. The cytotoxicity was considered as  low (+) when 
the values were within the range of 31.251>15.625>7.813 [cm²/ml], intermediate (++) for the 
values >3.906>1.953>0.977 [cm²/ml], and high (+++) for >0.488>0.244>0.122>0.061. The lack 
of cytotoxicity was reported when the absorption value exceeded 31.251 [cm²/ml] (Gareis, 
1994). 
In own researches for 57 isolated strains – A. fumigatus, A. ochraceus, A. niger, A. flavus, A. 
versicolor and A. ustus, as many as 48 (84%) were cytotoxic. It was also established that the A. 
niger species was considerably less cytotoxic than A. ochraceus and A. fumigatus (p<0.05)  
(Fig 4).  
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Legend: the squares at the middle represent the mean value of the estimated cytotoxicity, and the 
vertical lines represent the size of the confidence interval of the estimated cytotoxicity. 
Fig. 4. Intervals of confidence 95% CI and mean value of Aspergillus cytotoxicity estimated as 
difference between reference level equal to 50 and measured value of IC 50 cm2/ml.  
Research has shown that among all of the examined strains the strains of A. fumigatus, but 
not of other species, were either of intermediate or high cytotoxicity (Gniadek et al., 2011). 
Particularly, eight out of nine strains isolated from indoor air in adult intensive care unit 
were cytotoxic. High cytotoxicity was found in the following species: A. fumigatus, A. 
ochraceus and A. flavus, while the cytotoxivity of A. niger was intermediate or lacked 
cytotoxicity altogether (Gniadek et al., 2009). A further confirmation of those findings was 
brought by another study in which the highest fungal virulence towards murine 
macrophages was found in A. fumigatus, while the lowest in A. niger and A. terreus (Kamei et 
al., 2002).  
The considerable cytotoxicity of fungi isolated from the environment where 
immunocompromised patients are present encourages intensifying observations concerning 
the influence of environmental mycobiota on human health. Cases of aspergillosis caused by 
airborne infections were observed (a patient with aspergilosis infected two other patients in 
the same intensive therapy unit by airborne route). Recent literature does not provide 
evidence what level of exposure to toxin producing fungi may be dangerous to the health 
(Pegues et al., 2002). Nevertheless, there is a common opinion that moulds present indoors 
may be dangerous and the environmental conditions must be improved. The measurements 
of environmental occurrence of fungi indoors should include an evaluation of their 
cytotoxicity when the fungi are known to be toxic. Those measures should be habitual and 
preventive because evaluation after occurrence of infection will only reflect estimaton of risk 
at the initial stage of the disease and may not reflect the exposure to harmful substances in 
the course of the disease. It seems a fair policy that as preventive treatment for patients with 
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compromised immunity, in order to contain the exposure, the mycological cleanliness of 
hospital environment should be monitored, inclusive of marking the cytotoxicity of fungi 
commonly labelled pathogenic.  
5. Conclusion 
From the epidemiological point of view, the results of exposure to a mix of mycotoxins and 
other noxious substances present in the air we breathe indoors remain unknown. Therefore, 
the adverse effect of fungi to human health may be evaluated by means of finding the 
relationship between the disease (predisposition) and exposure level (detection of 
pathogenic spores) in relation to symptoms typical for experimental conditions caused by 
myotoxins. 
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